Inventor · disambiguated record
Santhosh F. Neelamkavil
Also filed as: NEELAMKAVIL SANTHOSH · NEELAMKAVIL SANTHOSH F · NEELAMKAVIL SANTHOSH FRANCIS
25 granted patents·14 pending applications·45 citations·filing 2002–2025
93Inventor score
Files withMERCK SHARP & DOHME13NEELAMKAVIL SANTHOSH FRANCIS6MERCK SHARP & DOHME LLC4JANSSEN BIOTECH INC3JANSSEN PHARMACEUTICA NV3
Top patents by PatentIndex Score
39 records- 0186US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0285US11939361B2Compositions of peptide inhibitors of Interleukin-23 receptorJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Mar 26, 2024·2 cites·16 claims
- 0384US9809545B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·4 cites·7 claims
- 0484US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 0583US8815876B2Bicyclic heterocycle derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Aug 26, 2014·7 cites·16 claims
- 0679US10123995B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Nov 13, 2018·2 cites·14 claims
- 0778US12030872B2N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 9, 2024·2 cites·15 claims
- 0878US11161854B2Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 0976US10239863B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Mar 26, 2019·1 cites·19 claims
- 1076US9580396B2C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2013·Granted Feb 28, 2017·3 cites·16 claims
- 1174US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 1273US12281114B2NK3 modulators and uses thereofKALLYOPE INC·Filed 2024·Granted Apr 22, 2025·0 cites·20 claims
- 1371US8822480B2Bicyclic heterocycle derivatives and use thereof as GPR119 modulatorsNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Sep 2, 2014·1 cites·19 claims
- 1470US6620972B2Method of oxidizing an alcohol using a recyclable fluorous sulfoxideUNIV ILLINOIS·Filed 2002·Granted Sep 16, 2003·3 cites·19 claims
- 1567US12478617B2Lipidated peptide inhibitors of interleukin-23 receptorJANSSEN BIOTECH INC·Filed 2023·Granted Nov 25, 2025·0 cites·40 claims
- 1665US9676723B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jun 13, 2017·1 cites·16 claims
- 1765US9663527B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted May 30, 2017·1 cites·14 claims
- 1864US2024254180A1Compositions of peptide inhibitors of interleukin-23 receptorJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1963US2024279281A1Peptide Inhibitors of Interleukin-23 ReceptorJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2062US2025188057A1Non-aromatic cyclic-pyrimidine analogs as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2158US2024352073A1Bicyclic peptide inhibitors of interleukin-23 receptorJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2258US2016257668A1Factor XIa InhibitorsSHAO NING·Filed 2014·Application pending·0 cites
- 2357US2024409598A1Peptide inhibitors of interleukin-23 receptorJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2456US2025263410A1Nk3 modulators and uses thereofKALLYOPE INC·Filed 2025·Application pending·0 cites
- 2555US2024308980A1Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2653US6849767B2Method of hydroborating alcohols and reducing functional groups using a recyclable fluorous borane-sulfideUNIV ILLINOIS·Filed 2003·Granted Feb 1, 2005·1 cites·24 claims
- 2750US2011129542A1Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1SCHERING CORP·Filed 2008·Application pending·0 cites
- 2850US2011118286A1Bicyclic heterocycle derivatives and their use as gpcr modulatorsNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Application pending·0 cites
- 2948US12319671B21-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 3, 2025·0 cites·16 claims
- 3048US2010190687A1Pyrimidinone derivatives and methods of use thereofBOYLE CRAIG D·Filed 2008·Application pending·0 cites
- 3146US11174248B2Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 16, 2021·0 cites·11 claims
- 3246US2016229839A1Factor XIa InhibitorsMERTZ ERIC·Filed 2014·Application pending·0 cites
- 3344US8912206B2Pyrimidine ether derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2010·Granted Dec 16, 2014·0 cites·10 claims
- 3440US9944643B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·0 cites·10 claims
- 3539US9409918B2Bridged bicyclic piperidine derivatives and methods of use thereofHARRIS JOEL M·Filed 2010·Granted Aug 9, 2016·0 cites·7 claims
- 3638US10214512B2Factor XIA inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 26, 2019·0 cites·14 claims
- 3735US8987242B2Morpholinone compounds as factor IXA inhibitorsCHACKALAMANNIL SAMUEL·Filed 2010·Granted Mar 24, 2015·0 cites·9 claims
- 3835US2012232073A1Fused bicyclic pyrimidine derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2010·Application pending·0 cites
- 3933US2012040975A1Bridged bicyclic heterocycle derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →